Pathomechanismen und Signaturen im Langzeitverlauf der Psychose

30.07.2019

2024-02-26

078_ Phenome-Wide Association Study (PheWAS) of Non-Cognitive Phenotypes using Polygenic Risk Scores for a Common Executive Function Factor and P-Factor

2024-02-14

077_ Identifying lipid alterations associated with psychopathological phenotypes

2024-02-13

076_ Investigating the association of inflammatory cytokines with psychopathology, and suicidal behavior in the PsyCourse Study: Genomic and proteomic analysis

2024-02-05

075_ Collaboration of PsyCourse with the International Suicide Genetics Consortium, which is now the PGC Suicide Working Group (Amendment to 027)

2023-05-19

074_ Role of discoidin domain receptor 1 (DDR1) and other cell cycle genes in the neurocognitive performance of patients with schizophrenia and with bipolar disorder

2023-06-15

073_ Differences in the centrality of cognitive domains and polygenic scores in affective and psychotic disorders: a network analysis

2023-05-08

072_ The influence of genetic liability for circadian rhythms alterations on bipolar disorder outcomes

2023-05-08

071_ The impact of polygenic risk score and early trauma on functioning and illness severity in bipolar disorder

2023-09-15

070_ Polygenic resilience scores for schizophrenia and childhood trauma in the psychosis continuum

2023-09-23

069_ Predicting mental health outcomes via large-scale integration of polygenic risk scores

2023-07-06

068_ Contributions of Polygenic Risk Scores for Genomic Common EF- and P-Factors to Longitudinal Variation in Cognitive Performance

2023-05-16

067_ Collider Bias Affects Genetic Prediction in Psychotic Disorders

2023-06-10

066_ Assessment of LipidQTLs in the PsyCourse Study (amendment to 031)

2023-06-10

065_ Outlier analyses in whole blood transcriptomes to identify rare genetic variants in individuals with schizophrenia (Amendment to 041)

2023-03-01

064_ The genetic burden of rare and potentially damaging variants in the schizophrenia risk-locus Xq28,distal

2021-10-28

063_ Proteomic blood biomarker signature for prediction of poor clinical outcome in affective and non-affective Psychosis: Pilot Study

2022-07-28

062_ Explore sex differences regarding clinical, neuropsychological and psychosocial variables in the Psycourse sample in patients with bipolar disorder and schizophrenia.

2022-12-14

061_ Investigating the effect of metabolic syndrome components in cognitive performance of patients with bipolar disorder, schizophrenia and depression

2022-10-01

060_ Stability of employment and relationship status over time in patients from the affective-to-psychotic spectrum

2022-10-21

059_ The impact of early life stress on global functioning, quality of life and symptomatic burden in patients from the affective-to-psychotic spectrum and healthy controls

2022-01-28

058_ Replication study: Identification and characterization of schizophrenia patient strata using genotype imputed transcriptional profiles

2022-05-18

057_ Unsupervised Clustering of Multiomics Data to Link Biotypes to Diagnosis and Outcome Parameters in PsyCourse

2022-04-05

056_ Investigating the association of plasma lipidomic profile with cognitive performance in the PsyCourse Study

2022-04-26

055_ Contributions of Polygenic Risk Scores for Genomic Common EF- and P-Factors to Cognitive Performance

2022-03-23

054_ Assessment of miRNA-eQTLs in the PsyCourse Study

2022-04-25

053_ Investigating the phenotypic and genetic predictors of study attrition in participants of mental health studies

2022-02-17

052_ Comorbidity analysis of schizophrenia patients using transcriptomic comorbid signatures

2022-03-22

051_ Analysis of schizophrenia patients using subgroup specific transcriptomic signatures

2021-12-15

050_ Characterization of early and late onset in older adults with bipolar disorder (OABD)

2022-02-04

049_ Replication study: Kernel Machine Regression Analysis of Networks considering the longitudinal course of phenotypes

2021-12-10

048_ Multi-level integrative omics to identify biomarkers in schizophrenia and other major psychoses (MulioBio): Classification based on psychopathology and cognitive profile

2021-11-29

047_ Predominant polarity: investigating the effect of manic episodes in cognitive performance of patients with bipolar disorder

2021-11-25

046_ Mitochondrial-related genes variants in major psychiatric patients of the PsyCourse study

2021-07-06

045_ Analysis of the interaction of PRS with childhood trauma and life events and its role in clinical outcomes in the PsyCourse dataset

2021-07-05

044_ Blood-based transcriptome signatures of suicidality

2021-07-12

043_ Developing a polygenic score for lithium treatment response

2021-03-11

042_ An integrative genomic and proteomic data approach to identify relevant circulating pQTLs to psychiatry

2021-03-08

041_ Outlier analyses in whole blood transcriptomes to identify rare genetic variants in individuals with schizophrenia

2021-03-04

040_ An integrative genomic and proteomic data approach to identify biomarkers related to cognition of bipolar disorder and schizophrenia patients

2021-02-25

039_ An integrative genomic and proteomic data approach to identify biomarkers related to psychopathology of bipolar disorder and schizophrenia

2020-12-02

038_ Genetic contributions to transdiagnostic symptom dimensions in patients with major depressive disorder, bipolar disorder, schizoaffective disorder, and schizophrenia

2020-11-16

037_ Multi-level integrative omics to identify biomarkers in a Schizophrenia and other major psychoses (MulioBio): SmallRNAome comparison of broad diagnostic groups

2020-07-13

036_ Genotype-Phenotype Correlations of the COVID-19 Host Genetics Initiative

2020-06-30

035_ Circulating smallRNA as biomarker for neuropsychiatric diseases: investigating differences in the miRNAome of schizophrenia patients

2020-05-22

034_ Impact of cognition and education on medication adherence in patients with psychotic and affective disorders

2020-04-26

033_ Circulating smallRNA as biomarker for neuropsychiatric diseases: investigating cross-sectional differences in the miRNAome of depression patients

2020-05-15

032_ The LiLi-Study: Lipidomics in Lithium Treatment and Response in PsyCourse

2020-05-15

031_ Assessment of LipidQTLs in the PsyCourse Study

2020-05-04

030_ Phenotypic variability of cognitive, psychosocial functioning, and symptomatic data in the PsyCourse cohort.

2020-04-30

029_ Analysis of the influence of polygenic risk on lifetime cannabis use in PsyCourse cohort

2020-04-15

028_ Molecular mechanisms linking psychiatric medications to biological age

2020-04-08

027_ Collaboration of PsyCourse with the International Suicide Genetics Consortium

2020-04-06

026_ Influence of Early Life Stress on cognition, psychopathology, level of Functioning in patients with schizophrenia

2020-02-13

025_ Multimodal stratification and comorbidity analysis in the PsyCourse sample using cross sectional approach (Pilot Study).

2020-01-15

024_ Preparatory work for the MulioBio project

2019-11-19

023_ Genetic and phenotypic determinants of disease onset in bipolar disorder.

2019-09-30

022_ Investigation of the genetic correlates of chronic disease course in the PsyCourse sample

2019-09-27

021_ Providing a use case of longitudinal data for the manuscript "Phenendo: a tool for clustering of cross-sectional and longitudinal phenotype data"

2019-09-16

020_ Weighted-gene correlation network analysis of lithium response

2019-08-19

019_ Genetic association and protein-protein interaction networks between MC4R and obesity in bipolar affective disorder

2019-07-08

017_ A Genome-Wide Association Study of the Longitudinal Course of Executive Functions

2019-07-03

016_ Polygenic Risk Scores across the extended psychosis spectrum

2019-08-27

015_ Genetic background of suicide: influence of various polygenic loads on suicidal behavior

2019-05-23

014_ Transcriptional profiling of SCZ and BD patients and the association of innate immunity markers with clinical treatment

2019-05-21

013_ Novel tissue-specific functional risk score model using eQTL prior in cross-disorders

2019-05-13

012_ An investigation of transdiagnostic psychosis subgroups with prognostic and genetic validation

2019-04-23

009_ Analyzing cognitive performance of diagnostic groups on the affective-psychotic continuum and its association with polygenic risk scores for schizophrenia, bipolar disorder and major depressive disorder

2019-04-06

008_ Influence of Personality Traits on Medication Adherence

2019-01-14

005_ Polygenic risk score analysis of trajectories of cognitive performance in psychiatric patients

2018-11-12

004_ Investigating the association of age at onset in schizophrenia patients with genetic/polygenic risk factors

2018-11-12

003_ Brain cell type-specific polygenic risk in schizophrenia: influence on clinical phenotypes

2018-09-13

002_ Investigating the association of educational attainment polygenic risk scores with cognitive performance in the PsyCourse cohort

2018-06-19

001_ Identification of causal factors of functional outcome in affective and non-affective psychosis